↓ Skip to main content

Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefits

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, April 2021
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
4 Mendeley